Opioid commission leader suggests it use at least $42 million to get exotic psychedelic drug approved to treat opioid-use disorder
The head of the commission that manages Kentucky’s opioid-settlement money said Wednesday that the panel will “explore the possibility” of committing “no less than $42 million” to developing a treatment